HDYO Research Video Series: uniQure Update

This edition of the HDYO Research Video Series looks at the HD Buzz article, "Buckle in: Gene therapy AMT-130 appears to slow down signs of Huntington’s disease in Phase I/II clinical trial". This article focuses on the update from uniQure who released data that appears to show hints of slowing down signs and symptoms of HD and appears safe.
To read the complete article: en.hdbuzz.net/372
Research Video Series is sponsored by Roche, Sage Therapeutics, Teva Pharmaceuticals, uniQure, Wave Life Sciences, Griffin Foundation and Neurocrine Biosciences.